Replies to post #25448 on BioSante Pharmaceuticals, Inc. (BPAX)

[QyQ]

ANI informations

ANI had approximately $11,000 in cash, cash equivalents and short-term investments and unused availability under its line of credit of approximately $935,000 (Initially I thought ~$200k)

ANI has not generated positive cash flows from operations. To bridge the gap between revenues and operating and capital needs, ANI has relied on a variety of financing sources, including the issuance of equity securities and convertible notes and revolving lines of credit. Based on projected revenue and expenses for the next twelve months, ANI anticipates that current cash on hand and borrowing availability under its revolving line of credit will be sufficient to meet ongoing expenses and capital requirements at least through the next twelve months, assuming the pending merger with BioSante is not completed.
(So, who is surviving company here? Year ended 2012, ANI net loss ~$1.5 million, why they said making money??)

Company with so low cash and not making money but pay so much amount of bonuses? You kidding me?